Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of OCH-NCNP1 in Patients With Relapsing Multiple Sclerosis

NCT04211740 is registered in ClinicalTrials.gov with National Center of Neurology and Psychiatry, Japan as lead sponsor.

NCT NCT04211740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04211740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of OCH-NCNP1 in Patients With Relapsing Multiple Sclerosis
Lead sponsor
National Center of Neurology and Psychiatry, Japan
Phase
Phase 2
Overall status
Completed
Start date
December 6, 2019
Completion date
May 31, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, relapsing-remitting, multiple sclerosis, secondary progressive